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Soon after broad spectrum antibiotic drugs became available for therapy,
reports appeared in the literature describing moniial infections of the anogenital
area and oral mucosa. Cannon (1) reported on the considerable amount of at-
tention being centered upon the problem of the rising frequency of monilial
infections in relation to antibiotic therapy.
Loh and Baker (2) studied the fecal flora of 19 normal subjects following the
administration of broad spectrum antibiotic therapy and found that in most in-
stances there was rapid 100-fold to 1000-fold increase of Candida albicans. In four
patients who had previously shown no yeasts, the presence and proliferation of
yeasts was observed during and following medication. They concluded that the
growth of yeasts seemed to be stimulated by the antibiotics either directly or
indirectly through suppression of other organisms.
Valentine (3) also reported on superinfection with Candida albicans when high
concentrations of broad spectrum drugs reach the intestinal tract. He believed
that with the destruction of the sensitive organisms, the resistant yeasts, nor-
mally inhibited, can multiply and give rise to infection.
Carpenter (4) summarized the data from his hospital and concluded that anti-
biotic therapy rendered conditions favorable for the growth of certain fungi by
suppression or alteration of the bacteria in common hosts.
Norris and Armstrong (5) in their publication stated that there has been an
in crease in the incidence of patients suffering from Candida albicans infections
and that this was caused, in part, by the prolonged use of antibiotics.
Seletz (6) reported on his observations during the past 12 years and con-
cluded that the incidence of fungi in the so-called intractable anogenital pruritus
cases ranged above 90 per cent, whether as primary or secondary invaders.
Bratlund and Holten (7) in reviewing the literature stated that the increasing
use of antibiotics is the main cause of the increasing incidence of moniiasis and
that adults are affected quite frequently.
Manheim and Alexander (8) reported on 300 cases of monilial anorectal com-
plications following oral ingestion of broad spectrum antibiotics.
Kligman (9) observed that Candida albicans regularly emerges in abundance
in the mouths and gastrointestinal tracts of those receiving wide spectrum anti-
biotics. Keefer (10) as well as Woods, Manning and Patterson (11) also reported
on oral, intestinal, bronchopulmonary, genital, dermal and generalized moniial
infections following the use of antibiotic therapy.
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There have been several reports on cases of fatal moniiasis following intensive
antibiotic therapy. Brown, Propp, Guests, Beebe and Early (12) had five; Zim-
merman (13) had three; Schaberg, Hildes (14) and Wilt had two; Rankin (15)
had one; and Gausewitz, Jones and Worbey (16) had one.
In some publications, the investigators erroneously implied that the antibiotic
drugs were the causative agents in producing moniliasis. It is now generally
accepted however: (1) that Candida albicans is a common inhabitant of the
gastrointestinal tract, oral cavity, vagina and skin; (2) that the broad spectrum
antibiotics destroy the gram negative and gram positive bacteria which are
competing with the co-existing Candida albicans for the same nutritive require-
ments; and (3) that the suppression of the gram negative and gram positive
bacteria allows for a more profused growth of the Candida albicans which may
result in clinical moniliasis. In addition, some authors believe that the patho-
genicity of the Canida albicans is enhanced.
In a recent communication, Robinson (17) describes the incrimination of
moniliasis as the cause of numerous adverse reactions to antibiotics and the un-
favorable publicity in the lay and medical press which has falsely stigmatized
these valuable therapeutic agents. He cultured Candida albicans prior to anti-
biotic therapy from the intestinal flora of 16 per cent of normal individuals, from
the vaginal tracts of 15 per cent of normal pregnant women and from the on-
pharynx of 14 per cent of normal individuals. Furthermore, the incidence of
finding this organism was not affected or influenced by antibiotic therapy. Robin-
son believes that the development of moniliasis is due to lowered resistance to
the invasion of Candida albicans and not to the antibiotic therapy. In cases of
clinical moniliasis which develop following antibiotic therapy, Robinson is of
the opinion that the increased severity of the condition is probably due to the
suppression of organisms which normally utilize the nutritive substances allowing
for an overgrowth of Candida albicans.
Dermatologists have had many instances of oral and vaginal infections, in-
volvement of the skin and finger-nails as well as anorectal disease which had been
due to Candida albicans long before the advent of the antibiotics. It would be
important to know just what happens to such patients after long exposure to
antibiotics and whether or not it is this type of patient who represents a special
potential hazard on exposure to mycin therapy.
Perhaps patients with known but minor Candida albicans infections bear the
same relationship to side reactions following antibiotic therapy as does the pa-
tient with dermatophytosis to reactions following penicillin (18). It would be
very helpful, if a skin test or other diagnostic procedure could be developed to
foretell with any degree of certainty which of our patients are potential candi-
dates for troublesome complications.
Various antigens have been prepared from Candida albicans to be used in skin
testing. Unlike the trichophytin test the oidiomycin reaction has been found to
be of little practical clinical significance. It was natural, therefore that attention
should have been focused on the complement fixation test as a diagnostic tool.
T. Benedek in 1928 (19) reported on his complement fixation test with Candida
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albicans. The antigen was prepared from fresh, richly grown cultures which were
washed with sodium chloride solution and then put in a shaking machine. These
culture infusions were kept for several days at 37—60° C. 0.5 cc phenol was then
added as a preservative. After being allowed to settle the supernatant fluid was
used as an antigen. The complement fixation test was carried out in the same way
as for the Wassermann reaction.
In 1928 Richter (20) reported a positive complement fixation test in a man with
a deep fluctuating tumor of the neck from which Candida albicans was isolated.
The patient died soon afterwards with a generalized infection in nearly all internal
organs. Richter could show that the same organism after repeated intradermal
inoculation in guinea pigs was also able to elicit positive complement fixation
tests in the animals after ten days.
H. Biberstein and Stephen Epstein in 1932 (21) seemed to have carried out the
most extensive study of the value of the complement fixation test in Candida
albicans infections using an antigen similar to the one described by Benedek
(19). Their antigen was prepared from Candida albicans isolated from cases of
thrush. In their series, they had positive reactions of only 3.5% in 729 normal
controls. In 99 cases of humans with proven Candida albicans infection, mostly
intertriginous and interdigital, there was a positive complement fixation test
of 45.4%. In 136 human cases with suspected Candida albicans infection there
was a positive complement fixation test of 24.3 %.As a rule repetition of the test
gave the same result. There was no strict parallelism between complement fixa-
tion test and cutaneous reaction.
Positive complement fixation tests could be obtained in guinea pigs after
inoculation of live cultures but not after inoculation of kified organisms or
extracts. In human cases intradermal reactions with the antigen were as a rule
stronger in those with evident Candida albicans infection than in normal cases,
but they were unsuccessful in finding the right concentration of antigen which
uniformly gave positive skin tests in evident infection and negative tests is so
called normals.
MATERIALS AND METHODS
Preparation of antigen
Many filtrates were made. The best antigen was obtained from Candida albi cans isolated
from the throat of a child with a fatal case of generalized moniliasis. In our series approxi-
mately one out of 8 organisms isolated from various Candida infections gave us a good
antigen.
Once a good antigen was obtained, it was quite stable and could be kept in solution in the
refrigerator (6°C) for months or even years. An aqueous antigen prepared in 1951 still con-
tinues to give us good results. It was this antigen which was used in most of the complement
fixation tests (MCFT) about to be reported.
Aqueous antigen
Candida albicans cultures were obtained from scrapings of patients. Blake bottles (1 liter
capacity) containing 100 cc. Sabouraud's agar were seeded with 3 ml. of a broth subculture
of the Candida albi cans. The agar covered one side of the bottle to provide as much surface
area as possible and still allow for an excess of air in the bottle. The monilia cultures were
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allowed to grow at room temperature for 5 to 7 days, at which time the agar was covered
with an abundant growth.
The monilia cells were then harvested. Sterile distilled water was poured into the culture
bottles and the surface of the agar was gently scraped with a sterile glass rod. The culture
bottles were shaken and the cells were poured into another sterile flask. The surfaces of the
culture bottles were rinsed off two more times in order to collect as many of the cells as
possible which adhered to surface of agar and sides of flask.
The cell suspensions were placed in 250 cc. centrifuge bottles (round bottom) and centri-
fuged at 2000 r.p.m. for 15 minutes. The packed washed cells were dried in a hot oven 120°C
for six hours. Dried cells were ground to a powder in a mortar, weighed and placed in a 250
cc sterile centrifuge bottle in which glass beads had been placed. To each gram of powdered
cells 100 cc sterile distilled water was added. The cells were shaken vigorously in a fast
shaking machine 24 hours to further break up the cells and obtain the extract. After shaking,
the cells were packed by centrifuging at 2,000 rpm for 30 minutes. The supernatant was
decanted, centrifuged again and filtered through a Seitz.
Aqueous Antigen Heat Treated
A. Cells recovered from culture as in the above method. After centrifugation the dis-
dilled water was decanted and discarded. The packed cells which had been spun in a gradu-
ated centrifuge tube, were resuspended in distilled water in a 1:30 dilution, and sterilized
in the autoclave at 15 lbs. pressure for 30 minutes. The sterile cells were extracted by shak-
ing in the shaking machine for 24 hours. Allowed to settle out at room temperature over-
night, centrifuged to spin all cells to bottom of bottle. Supematant fluid filtered through a
Seitz filter.
B. Heat treated—no Seitz filtration. It was observed that the supernatant fluid was
opaque before filtering and clear after. The thought occurred that some fraction in the
extract might be lost in filtering through the Seitz.
Therefore some of the supernatant fluid was kept aside to be treated as follows: the fluid
was placed in centrifuge tubes and respun to remove any remaining cells, filtered through
two layers of Stancien Filter paper No. 222. The filtrate was still opaque, to insure complete
removal of cells the filtrate was again centrifuged (note: no cells recovered). This filtrate
used as an antigen for the serology gave more consistant results than the other antigens.
Alcoholic antigen
Prepared in same manner as the Aqueous but 100% alcohol substituted for the distilled
water.
This antigen was discarded because it gave too many false positives especially in patients
with positive serology for syphilis.
HC1 digested
Packed monilia cells suspended 1:30 in 10% HC1. Suspension placed in centrifuge bottle
containing glass beads, and agitated in shaking machine for 24 hours to digest and extract
monilia cells. The bottle was left out at room temperature overnight to allow cells to settle
out. Supernatant fluid decanted, neutralized with NaOH, and filtered through the Seitz
filter. Resulting filtrate used as antigen.
This antigen was also discarded as being unsuitable.
Quantitative Test
Two-fold serial dilutions are prepared of the patient's serum. The proportions of re-
actants is the same as in the qualitative test.
EVALUATION OF THE MONILIA COMPLEMENT FIXATION TEST (MCFT)
In order to evaluate the specificity of an sensitivity of the monilia complement
fixation test, the serums of 793 clinic and private patients with a variety of
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TABLE I
Monilia complement fixation technic (MCFT)
Qualitative Test Test Control
Overnight at 4°C.
ml. ml.
Patient's serum 0.1 0.1
Veronal 0.2 0.5
Buffered saline complement
3—50% iJnits* monilia antigent
0.3
0.3
0.3
37°C. water bath—30 minutes
Sensitized sheep cells 0.6 0.6
* This technic is that described by Dr. John F. Kent (the Army Medical Service Graduate
School, Washington, D. C.) for a Serologic test for syphilis.
f The monilia extract is first subjected to an anti-complementary and a hemolytic
titration. It is then subjected to an antigen titration to determine the dilution which
presents the highest degree of sensitivity with a serum from a known positive moniliasis
patient. Employing this dilution of antigen, a large number of serums from normal patients
are tested to evaluate the specificity of the antigen.
dermatoses, were subjected to this procedure. Of these, 686 or 86.5 per cent
gave negative reactions, whereas, 96 serums were strongly reactive and 12 serums
were weakly reactive for a total positivity of 13.5 per cent. Whenever possible,
duplicate specimens, as well as serums obtained at various intervals from the
same patients were tested together on one day and the reproducibility of the
results was excellent. Many of the positive serums were subjected to quantitative
testing and here again the reproducibility of results was exceptionally good.
Serums were also obtained from 120 seropositive treated syphilitic individuals
of which 21 or 17.5 per cent were reactive with the moniia complement fixation
test. Although the incidence of reaction was higher in the syphilitic as compared
to the nonsyphilitic group, it was of special interest that nearly 80 per cent of
serums with strongly positive serologic tests for syphilis were completely negative
with the moniia complement fixation test. This would indicate that the moniia
antigen employed did not contain any Wassermann reacting lip oidal substances.
In contrast, serums were collected from 48 patients with clinical moniliasis,
of the axilla, groins, inframammary areas and periungual tissues, of which 34
were strongly reactive and 2 were weakly reactive for a total seropositivity of 75
per cent.
In order to correlate the incidence of Gandida albicans in stool cultures with
the monilia complement fixation test the following experiment was conducted.
The number of yeasts per gram of stool was determined in a series of 50 patients
before, during and after tetracycline therapy. The average of 2 to 3 specimens
taken on separate days was used to denote the yeast index. Serum specimens
were collected from these patients and subjected to the moniia complement
fixation test. There was no correlation between the stool culture findings and the
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complement fixation test results. Some individuals with a high yeast count of
120,000 gave a negative result with the complement fixation test whereas some
with negative stool cultures gave strongly positive serologic reactions.
An attempt was made to determine the effect of long term tetracycline therapy
on the moniia complement fixation test. A series of 186 patients with pustular
dermatoses were selected for the study. There were 110 females and 76 males
with ages varying from eleven to sixty-two years. The majority of patients in this
series had pustular acne vulgaris. They received one or two grams of tetracycline
therapy per day for one month or longer. Of these, 112 patients were kept on a
maintenance dose of 250 mg to 1 gram per day for periodsvarying up to 4 months.
Serum specimens for examinations with the monilia complement fixation test
were collected before, during and after completion of therapy.
In this series 27 or 14.5% were reactive with the monilia complement fixation
test. It was of special interest that in only three instances, was the moniia com-
plement fixation test negative prior to treatment and became weakly reactive
following therapy. In all remaining patients the serologic results were negative
before, during and after treatment.
There apparently was no correlation between the monilia complement fixation
test results and the incidence or degree of gastro-intestinal complaints such as
nausea, vomiting, cramps, diarrhea or fiatus. There was, however, a marked
correlation between the positive serologic results and the development of ano-
genital pruritus. Of the 27 seropositive reactors 21 (81 %) developed this condi-
tion shortly after the institution of tetracycline therapy.
SUMMARY
The historical background of the status of the MCF in the Sero-Diagnosis of
moniliasis has been discussed.
The pleparation of a sensitive and specific monilial antigen and the technic
for employing this antigen has been described.
The incidence of positive reactions with this test in a series of 793 patients with
a variety of unselected dermatoses was 13.5%.
The incidence of positive MCF results in a series of 120 sero-positive treated
syphilitics was 17.5%, indicating that this antigen does not contain any Wasser-
mann-reacting lipoidal substances.
In a series of 48 patients with clinical moniliasis 36 or 75% gave positive MCF
tests.
There was no correlation between positive stool cultures and MCF results in
a series of 50 patients.
In a series of 186 patients with pustular skin diseases, long term tetracycline
therapy did not affect MCF results. Those who were sero-negative prior to
therapy remained sero-negative in individuals under therapy for as long as 4
months.
There was no correlation between MCF and the incidence or degree of gastro-
intestinal complaints, such as nausea, vomiting, cramps, diarrhea or fiatus.
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There was a marked correlation between MCF results and the development
of ano-genital pruritus. Of the 27 sero-positive reactors prior to tetracycline
therapy, 21 (81 %) developed ano-genital pruritus shortly after institution of
therapy.
The authors are indebted to Dr. Morris Waisman for supplying some of the serums and
to Mrs. Celia Pearistein and Miss Bianca Pollio for their technical assistance.
TIns studywas partly aided hy a grant from Bristol Laboratories, Inc., Syracuse, N. V.
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DISCUSSION
DR. TIBOR BENEDEK (Chicago, Ill.): I would like to say a few words to the
excellent presentation of Dr. Peek.
He referred to my paper of 1928, which was followed by another in collabora-
tion with Alice Reinhart in 1932 and was published in Zbl. Bacteriologic. The
conditions under which he conducted the investigations and our conditions were
entirely different. He checked patients under tetracycline therapy and we
checked the patients to see whether we could use the complement-fixation test
as another evidence for the pathogenicity of the B. endoparasiticus Benedek,
1927. In both papers, we came to the same conclusion concerning this serological
test; that it is equivocal, confusing and not contributory in any way to the
establishment of etiological relationship. The monilial antigen proved itself
completely unspecific. However, he made a very excellent point—and I would
like to compare his findings with another one in the literature, that is, the Weil-
Felix reaction in typhus, where proteus X- 19 is used with great specificity without
etiological conclusions. Despite this peculiar fact, no one has ever stated that
typhus is not a virus disease, but is caused by proteus X-1 9.
DR. J. WALTER WILsoN (Los Angeles, Calif.): This is an extremely compli-
cated subject, nsing antigens from various materials as testing agents. If we are
not very careful we tend to make it much simpler than it is. For example, we are
always considered fantastically naive when we speak of coccidioidin testings
as furnishing information with which we can reliably predict the clinical course
of a patient's illness because we attribute certain results to this testing procedure
which experience with tuberculosis leads one to believe are absolutely not true.
It is completely forgotten that the same things are not being compared. One
cannot compare eggs and apples beyond the resemblance in shape. As far as the
skin test with coccidioidin is concerned, we work with an absolutely pure poly-
saccharide, containing no nitrogen, therefore with no protein component whatso-
ever. The tuberculin test, on the other hand, is done with pure protein. One
cannot transfer the results to be expected from one to the other without proof.
It is also very wrong to assume that the response to skin test means the same as
response to complement-fixation because, in coccidiomycosis they are the exact
antithesis. The skin test can measure the patient's resistance to the disease
whereas the complement-fixation test measures the amount of active disease he
has to fight. There is no similarity between the two tests. Whenever working with
one of these antigen materials I suggest wherever possible that these materials
he separated into lipoid, polysaccharide and protein fragments and the test be
conducted in triplicate using all of those fractions, in an effort to learn as much as
possible the significance of the results.
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DR. FREDERICK KALZ (Montreal, Quebec): I should like to ask one question,
which Dr. Peck has already remarked on in his excellent presentation. With the
refinement of mycological technics on the one hand, and the widespread use of
the antibiotics on the other hand, we are getting more and more positive myco-
logical laboratory reports. It is often difficult to decide whether such reports
demonstrate merely the presence of Candida albicans as a parasite in a given
patient or whether the causative organisms of whatever clinical symptoms may
be present is thereby revealed.
We have demonstrated a heavy growth of Candida albicans in psoriasis lesions,
and in a variety of eczematous disorders and the number of positive stool cul-
tures particularly after antibiotic therapy appears to be increasing. I should
like to ask Dr. Peck to what extent were positive serologic findings correlated not
to the presence of monilia but to their pathogenicity in a givell case. I under-
stand that a satisfactory correlation has been established in one instance, namely
in perianal pruritus.
DR. ADOLPH ROSTENBERG, JR. (Chicago, Ill.): I rise to discuss a point that Dr.
Peck and his colleagues did not explicitly make but I think there is strong in-
ference concerning it in their presentation. The point I question is the inference
that because one does not find any measurable antibody against a certain micro-
organism and yet finds growth of the organism, in this case monilia, the presence
of the organism has no meaning. Admittedly such a statement was not made,
but it seems to me that it was implied. The detection of antibody merely means
that the host has entered into some sort of immunological relationship with the
organism or antigens derived from it. Microorganisms can, of course, produce
damage or irritation by various means and we are certainly not in a position to
assert that damage will never follow unless some sort of antibody develops.
Furthermore, the complement-fixing antibody which was the one detected by this
technic is only one of several varieties of antibodies that can be developed;
consequently, the failure to find this type of antibody is no evidence whatsoever
that other types of antibody not searched for might not have heen present. In
the case where antibody was found, it is interesting, as Dr. Kalz mentioned, that
pruritus is apparently associated. Pruritus, we know, is often a concomitant or
byproduct of sensitization phenomena.
The relationship in the Weil-Felix reaction between rickettsia and the proteus
has been pretty well worked out. It is established that there is a carbohydrate
moiety common to both organisms and hence the cross-reaction.
DR. CHARLES R. REIN (in closing): On behalf of Dr. Peck, Miss Bergamini and
Miss Kelcec, I wish to thank Doctors Benedek, Wilson, Kalz and Bostenberg
for their interesting discussion.
Our data indicated that in only 3 patients did the results obtained with the
monilia complement-fixation test change from non-reactive to reactive. All
other patients who were seronegative prior to long term tetracycline therapy
remained seronegative on completion of treatment. Of special interest was the
observation that 90 per cent of those who were seropositive prior to tetracycline
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therapy, developed anogenital pruritus in 4 to 10 days after the oral administra-
tion of this antibiotic. Furthermore, there was no correlation of the incidence and
severity of gastro-intestinal side effects, such as nausea, vomiting, diarrhea and
flatus, and the results of the monilia complement-fixation test.
Through the courtesy of Doctors Victor Newcomber and Harry Robinson, Jr.,
we received blood specimens from patients in whom stool cultures for Candida
albicans had been made. Here, again, there was no correlation between the posi-
tive stool cultures and the positive monilia complement-fixation results. On the
other hand, there was a high incidence of positive serologic reactions with serums
from patients with clinical cutaneous moniliasis.
